Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia, a sweeping new study suggests
*Vic tim GIP/GLP-1 ti bnh vin ca chng ti khng c bo him chi tr
Wu SX, Zhao XY, Yang YH, Zhou MQ, Zheng Y, Wu ZJ, Zou QY, Zhang TT, Du L
COM To view or add a comment, sign in The proliferation of high-alcohol content beverages presented a significant challenge to the traditional alcohol industry
The guiding principle is to find the lowest effective dose that comfortably sustains continued outcomes for the long term, rather than rushing everyone to the maximum dose in the minimum time